These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
15. Elevated thyroid indices in children and adolescents with obsessive-compulsive disorder: effects of clomipramine treatment. McCracken JT; Hanna GL J Child Adolesc Psychopharmacol; 2005 Aug; 15(4):581-7. PubMed ID: 16190790 [TBL] [Abstract][Full Text] [Related]
16. A case report of refractory obsessive-compulsive disorder improved by risperidone augmentation of clomipramine treatment. Kawahara T; Ueda Y; Mitsuyama Y Psychiatry Clin Neurosci; 2000 Oct; 54(5):599-601. PubMed ID: 11043813 [TBL] [Abstract][Full Text] [Related]
17. Pharmacotherapy of childhood obsessive-compulsive disorder. Leonard HL; Rapoport JL Psychiatr Clin North Am; 1989 Dec; 12(4):963-70. PubMed ID: 2690035 [TBL] [Abstract][Full Text] [Related]
18. Clinical features associated with treatment response in obsessive-compulsive disorder. Shavitt RG; Belotto C; Curi M; Hounie AG; Rosário-Campos MC; Diniz JB; Ferrão YA; Pato MT; Miguel EC Compr Psychiatry; 2006; 47(4):276-81. PubMed ID: 16769302 [TBL] [Abstract][Full Text] [Related]
19. Six-year follow-up after exposure and clomipramine therapy for obsessive compulsive disorder. O'Sullivan G; Noshirvani H; Marks I; Monteiro W; Lelliott P J Clin Psychiatry; 1991 Apr; 52(4):150-5. PubMed ID: 2016246 [TBL] [Abstract][Full Text] [Related]
20. An integrated approach to treatment of obsessive compulsive disorder. Greist JH J Clin Psychiatry; 1992 Apr; 53 Suppl():38-41. PubMed ID: 1532963 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]